gpt-oss-9.0b-specialized-health_or_medicine-pruned-moe-only-12-experts

<|channel|>analysis<|message|>Need explain differences: size, structure, replication, genetics, disease, treatment.<|end|><|start|>assistant<|channel|>final<|message|>**Bacteria vs. Virons – the “Micro‑Life” Showdown**

| Feature | Bacteria | Virons |
|--------- |----------- |----------- |
| **What they are** | Single‑cell, living organisms (pro‑ or e‑) that can grow and divide on their own. | Tiny particles that are not living cells; they are made of a small piece of genetic material (DNA or RNA) plus a protein shell. |
| **Size** | 1 – 10 µm (visible under a microscope). | 100 – 200 nm (usually invisible to light‑microscopy). |
| **Structure** | A cell with a membrane, ribosomes, DNA, and many organelles (e.g., mitochond‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑

<|channel|>analysis<|message|>Need to give overview.<|end|><|start|>assistant<|channel|>final<|message|>**Diabetes mellitus** is a chronic metabolic disorder in which the body cannot produce or use insulin effectively, leading to high blood glucose (hyper‑gly) levels.  The two main types are:

| Type | Pathophysiology | Typical onset | Key clinical features |
|------|-------------------|----------------|------------------------|
| Type 1 | Autoimmune destruction of β‑isβ‑cells → absolute insulin deficiency | Usually in 2–3 years of childhood, but can occur at any age | • Rapid onset of hyper‑gly; • Weight loss; • Poly‑urho; • Fatigue; • Re‑current infections (UTIs, thrung, skin) |
| Type 2 | Ins insulin resistance → relative insulin deficiency (often secondary) | Usually 10–20 years of adulthood; ↑ with obesity, inactivity, genetics | • Gradual hyper‑gly; • Weight gain; • Fatigue; • Peripheral neuropathy; • Retinopathy; • Cardi‑vascular risk |

---

## Symptoms (common across both types)

| Symptom | Why it occurs | Typical presentation |
|--------|----------------|------------------------|
| **Poly‑urho** | Kidneys ex‑glucose → water → urine | “Frequent” or “un‑controlled” ur‑frequency, especially in the 2–3 th decade |
| **Polod** | Osmos‑pressure ↑ → thirst | “Constant thirst” or “dring” for water/juice |
| **Weight loss** (Type 1) / **Weight gain** (Type 2) | Metabolic shift & insulin deficiency | Rapid weight loss in Type 1; gradual weight gain in Type 2 |
| **Fatigue / Mala** | Hyper‑gly & metabolic stress | “Feeling tired” or “weak” for days |
| **Infections** | Hyper‑gly imp‑immune | Re‑current UTIs, thrung, skin infections |
| **Neuropathy** | Chronic hyper‑gly → nerve damage | Tingting, numbness, pain in extremities |
| **Retinopathy** | Chronic hyper‑gly → micro‑vascular damage | Vision changes, floaters, blurred vision |
| **Foot ulcers** | Peripheral neuropathy + poor circulation | Painful, non‑healing wounds on toes/feet |
| **Cardi‑vascular symptoms** | Hyper‑gly + dyslip → atheros